ATE380794T1 - 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on- derivate mit pde iv und cytokin-inhibirendes aktivität - Google Patents

1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on- derivate mit pde iv und cytokin-inhibirendes aktivität

Info

Publication number
ATE380794T1
ATE380794T1 AT96909151T AT96909151T ATE380794T1 AT E380794 T1 ATE380794 T1 AT E380794T1 AT 96909151 T AT96909151 T AT 96909151T AT 96909151 T AT96909151 T AT 96909151T AT E380794 T1 ATE380794 T1 AT E380794T1
Authority
AT
Austria
Prior art keywords
phenylalkenyl
pde
dihydro
imidazole
derivatives
Prior art date
Application number
AT96909151T
Other languages
English (en)
Inventor
Eddy Freyne
Gaston Diels
Jose Ignacio Andres-Gil
Francisco Javi Fernandez-Gadea
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE380794T1 publication Critical patent/ATE380794T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96909151T 1995-04-06 1996-03-28 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on- derivate mit pde iv und cytokin-inhibirendes aktivität ATE380794T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200869 1995-04-06

Publications (1)

Publication Number Publication Date
ATE380794T1 true ATE380794T1 (de) 2007-12-15

Family

ID=8220174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909151T ATE380794T1 (de) 1995-04-06 1996-03-28 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on- derivate mit pde iv und cytokin-inhibirendes aktivität

Country Status (16)

Country Link
US (1) US5952510A (de)
EP (1) EP0819123B1 (de)
JP (1) JP3963475B2 (de)
KR (1) KR100400161B1 (de)
CN (1) CN1068590C (de)
AR (1) AR003412A1 (de)
AT (1) ATE380794T1 (de)
AU (1) AU703235B2 (de)
CA (1) CA2216546C (de)
DE (1) DE69637363T2 (de)
ES (1) ES2297837T3 (de)
IL (1) IL117808A (de)
MY (1) MY113446A (de)
TW (1) TW424087B (de)
WO (1) WO1996031486A1 (de)
ZA (1) ZA962755B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62939C2 (uk) * 1996-10-02 2004-01-15 Янссен Фармацевтика Н.В. Похідне 2-ціаноіміноімідазолу, фармацевтична композиція та спосіб одержання сполуки
SK284468B6 (sk) 1998-04-01 2005-04-01 Janssen Pharmaceutica N. V. Pyridínový derivát, spôsob jeho prípravy a použitie, kompozícia s jeho obsahom a spôsob jej prípravy
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
GB0321754D0 (en) * 2003-09-17 2003-10-15 Smiths Group Plc Apparatus
EP1987009A1 (de) * 2006-01-30 2008-11-05 Euro-Celtique S.A. Cycloharnstoffverbindung als calciumkanalblocker
NZ601967A (en) 2010-03-12 2015-03-27 Omeros Corp Pde10 inhibitors and related compositions and methods
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
CN107530313A (zh) 2015-04-24 2018-01-02 奥默罗斯公司 Pde10抑制剂以及相关组合物和方法
WO2017079678A1 (en) 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
PL3411368T3 (pl) * 2016-02-03 2020-11-16 Rigel Pharmaceuticals, Inc. Związki aktywujące nrf2 i ich zastosowania
CA3013080A1 (en) * 2016-02-03 2017-08-10 Rigel Pharmaceuticals, Inc. Nrf2 activating compounds and uses thereof
DE102017127776A1 (de) * 2017-11-24 2019-05-29 Henkel Ag & Co. Kgaa Hydrolyselabile Heterocyclen von Riechstoffketonen oder -aldehyden

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551417A (en) * 1967-08-28 1970-12-29 Universal Oil Prod Co Pesticidal heterocyclic sulfides
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
CA2095429A1 (en) * 1990-11-06 1992-05-07 Paul E. Bender Imidazolidinone compounds
BR9307570A (pt) * 1992-12-02 1999-05-25 Pfizer Diéteres de catecol como inibidores seletivos de pdeiv
GB9226830D0 (en) * 1992-12-23 1993-02-17 Celltech Ltd Chemical compounds
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
CA2150533A1 (en) * 1994-05-31 1995-12-01 Katsumi Itoh Production of optically active triazole compounds and their intermediates

Also Published As

Publication number Publication date
IL117808A0 (en) 1996-08-04
AR003412A1 (es) 1998-08-05
JPH11503137A (ja) 1999-03-23
AU703235B2 (en) 1999-03-18
CA2216546A1 (en) 1996-10-10
EP0819123A1 (de) 1998-01-21
CN1068590C (zh) 2001-07-18
IL117808A (en) 2001-01-11
DE69637363D1 (de) 2008-01-24
TW424087B (en) 2001-03-01
MY113446A (en) 2002-02-28
CN1181071A (zh) 1998-05-06
AU5275696A (en) 1996-10-23
DE69637363T2 (de) 2008-12-04
EP0819123B1 (de) 2007-12-12
JP3963475B2 (ja) 2007-08-22
US5952510A (en) 1999-09-14
KR19980703450A (ko) 1998-11-05
CA2216546C (en) 2009-01-06
ZA962755B (en) 1997-10-06
ES2297837T3 (es) 2008-05-01
WO1996031486A1 (en) 1996-10-10
KR100400161B1 (ko) 2004-02-05

Similar Documents

Publication Publication Date Title
NO974602L (no) 1,3-Dihydro-1-(fenylalkyl)-2H-imidazol-2-onderivater med PDE IV- og cytokinaktivitet
FI944803L (fi) HLE-estävää aktiivisuutta omaavia laktaamipeptidejä
DE68929305D1 (de) Oligoribonukleotid-Derivate und Verwendung davon als Antiviral Arzneimittel
FI943421L (fi) 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
DE69637170D1 (de) Zonenbasierte güterordnung und steuersystem
NZ237790A (en) Substituted benzimidazoles and medicaments.
DE3869167D1 (de) Phenyltriazol-derivate und insectizid.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
NZ307950A (en) Cyclic amidines derivatives and medicaments thereof
NO905485L (no) Benzazepin- og benzotiazepin-derivater.
DE69424051D1 (de) Rapamycin-derivat mit antimikrobe, antikrebs und immunomodulatorischer aktivität
DE69637363D1 (de) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on-derivate mit pde iv und cytokin-inhibirendes aktivität
ATE111477T1 (de) 2'-halomethyliden, 2'-ethenyliden und 2'-ethynyl- adenosinderivate.
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
MA22981A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique.
ATE305455T1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
DE58901101D1 (de) Heterocyclen auf piperazinopiperazinbasis und deren verwendung.
DE69311146D1 (de) Reinigung von Sensoroberflächen - Verfahren, Sensor und Reinigungselement
FI945672L (fi) Elastosoleja, niiden valmistaminen käyttöä varten sekä niistä tehtyjä tuotteita
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
FI950533L (fi) Seco-nukleosidien liponulkeotidit, niiden valmistaminen sekä niiden käyttö virusten vastaisina lääkkeinä
DE68919507D1 (de) 2-Pyridylmethylthio-Derivate und antiulzerierendes Mittel.
BR1100515A (pt) Derivados de amidina, sua preparação e utilização como medicamentos com ação antagonista de ltb4
FR2691147B1 (fr) Derives de 2-piperidinylpyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2691148B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties